Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Sponsor: GlaxoSmithKline
Summary
The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.
Official title: A Phase 2, Randomized, Double-blinded, Placebo-controlled Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2025-04-09
Completion Date
2028-07-10
Last Updated
2026-07-08
Healthy Volunteers
No
Interventions
Efimosfermin
Efimosfermin will be administered as a subcutaneous injection.
Placebo
Placebo will be administered as a subcutaneous injection.
Locations (30)
GSK Investigational Site
Chandler, Arizona, United States
GSK Investigational Site
Mesa, Arizona, United States
GSK Investigational Site
Tucson, Arizona, United States
GSK Investigational Site
Fresno, California, United States
GSK Investigational Site
Lancaster, California, United States
GSK Investigational Site
Pasadena, California, United States
GSK Investigational Site
Rialto, California, United States
GSK Investigational Site
Santa Maria, California, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Viera, Florida, United States
GSK Investigational Site
Marietta, Georgia, United States
GSK Investigational Site
Baltimore, Maryland, United States
GSK Investigational Site
Kansas City, Missouri, United States
GSK Investigational Site
New York, New York, United States
GSK Investigational Site
Fayetteville, North Carolina, United States
GSK Investigational Site
Wilson, North Carolina, United States
GSK Investigational Site
Austin, Texas, United States
GSK Investigational Site
Austin, Texas, United States
GSK Investigational Site
Austin, Texas, United States
GSK Investigational Site
Dallas, Texas, United States
GSK Investigational Site
Georgetown, Texas, United States
GSK Investigational Site
Houston, Texas, United States
GSK Investigational Site
Houston, Texas, United States
GSK Investigational Site
Houston, Texas, United States
GSK Investigational Site
Pasadena, Texas, United States
GSK Investigational Site
Pearland, Texas, United States
GSK Investigational Site
San Antonio, Texas, United States
GSK Investigational Site
San Antonio, Texas, United States
GSK Investigational Site
Waco, Texas, United States
GSK Investigational Site
Richmond, Virginia, United States